Integra LifeSciences Holdings Corporation (IART)
Automate Your Wheel Strategy on IART
With Tiblio's Option Bot, you can configure your own wheel strategy including IART - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol IART
- Rev/Share 21.2431
- Book/Share 12.701
- PB 0.0
- Debt/Equity 0.0
- CurrentRatio 0.0
- ROIC 0.0327
- MktCap 985391964.0
- FreeCF/Share 0.0453
- PFCF 284.5486
- PE -33.4847
- Debt/Assets 0.0
- DivYield 0
- ROE -0.0252
- Rating C
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 1
- D/E Score 1
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | IART | Argus | Hold | Buy | -- | -- | March 31, 2025 |
| Upgrade | IART | BTIG Research | Sell | Neutral | -- | -- | Oct. 7, 2024 |
News
Is the Options Market Predicting a Spike in Integra LifeSciences Stock?
Published: May 30, 2025 by: Zacks Investment Research
Sentiment: Neutral
Investors need to pay close attention to Integra LifeSciences stock based on the movements in the options market lately.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Shareholders to Learn More About the Investigation
Published: May 29, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 29, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation
Published: May 28, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 28, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Shareholders to Inquire about Securities Investigation
Published: May 27, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 27, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
Bronstein, Gewirtz & Grossman, LLC Encourages Integra LifeSciences Holdings Corporation (IART) Stockholders to Inquire about Securities Investigation
Published: May 23, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 23, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Integra LifeSciences Holdings Corporation (IART) and Encourages Investors to Learn More About the Investigation
Published: May 22, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 22, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
Bronstein, Gewirtz & Grossman, LLC Is Investigating Integra LifeSciences Holdings Corporation (IART) And Encourages Stockholders to Connect
Published: May 21, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 21, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 21, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Integra LifeSciences Holdings Corporation (IART) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation
Published: May 20, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 20, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 19, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 19, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against Integra LifeSciences Holdings Corporation (IART) And Encourages Investors to Reach Out
Published: May 16, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK CITY, NY / ACCESS Newswire / May 16, 2025 / Bronstein, Gewirtz & Grossman, LLC is investigating potential claims on behalf of purchasers of Integra LifeSciences Holdings Corporation ("Integra" or "the Company") (NASDAQ:IART). Investors who purchased Integra securities are encouraged to obtain additional information and assist the investigation by visiting the firm's site: bgandg.com/IART.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 13, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 13, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 09, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, May 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation (“Integra” or the “Company”) (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 08, 2025 by: Accesswire
Sentiment: Neutral
NEW YORK, NY / ACCESS Newswire / May 8, 2025 / Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ:IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Integra LifeSciences Holdings Corporation - IART
Published: May 06, 2025 by: PRNewsWire
Sentiment: Neutral
NEW YORK , May 6, 2025 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Integra LifeSciences Holdings Corporation ("Integra" or the "Company") (NASDAQ: IART). Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext.
Read More
Integra Q1 Earnings Miss Estimates, Stock Down, '25 EPS Outlook Cut
Published: May 06, 2025 by: Zacks Investment Research
Sentiment: Negative
IART's first-quarter 2025 earnings lag the consensus mark. Q2 revenue projections are bleak.
Read More
Integra LifeSciences Holdings Corporation (IART) Q1 2025 Earnings Call Transcript
Published: May 05, 2025 by: Seeking Alpha
Sentiment: Neutral
Integra LifeSciences Holdings Corporation (NASDAQ:IART ) Q1 2025 Earnings Conference Call May 5, 2025 8:30 AM ET Company Participants Chris Ward - Senior Director, Investor Relations Mojdeh Poul - President and Chief Executive Officer Lea Knight - Executive Vice President and Chief Financial Officer Conference Call Participants Young Li - Jefferies Iseult McMahon - BTIG Vik Chopra - Wells Fargo Lilia-Celine Lozada - JPMorgan Ravi Misra - Truist Securities Anthony Occhiogrosso - Citi Jayson Bedford - Raymond James Craig Bijou - Bank of America Securities Operator Good day and thank you for standing by. Welcome to the Integra LifeSciences First …
Read More
Compared to Estimates, Integra (IART) Q1 Earnings: A Look at Key Metrics
Published: May 05, 2025 by: Zacks Investment Research
Sentiment: Positive
The headline numbers for Integra (IART) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Read More
Is This the Right Time to Hold Integra Stock in Your Portfolio?
Published: March 26, 2025 by: Zacks Investment Research
Sentiment: Neutral
IART stays on investors' radar courtesy of its strong prospects in the CSS segment and international growth.
Read More
Integra Q4 Earnings Beat Estimates, Revenues Rise Y/Y, Stock Up
Published: March 03, 2025 by: Zacks Investment Research
Sentiment: Positive
IART delivers better-than-expected earnings in the fourth quarter of 2024.
Read More
INTEGRA ALERT: Bragar Eagel & Squire, P.C. is Investigating Integra LifeSciences Holdings Corp. on Behalf of Long-Term Stockholders and Encourages Investors to Contact the Firm
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
NEW YORK, Feb. 25, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Integra LifeSciences Holdings Corp. (NASDAQ: IART) on behalf of long-term stockholders following a class action complaint that was filed against Integra on September 12, 2023 with a Class Period from March 11, 2019 to May 22, 2023. Our investigation concerns whether the board of directors of Integra have breached their fiduciary duties to the company.
Read More
Integra LifeSciences Reports Fourth Quarter and Full-Year 2024 Financial Results and Provides 2025 Financial Guidance
Published: February 25, 2025 by: GlobeNewsWire
Sentiment: Neutral
PRINCETON, N.J., Feb. 25, 2025 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART) today reported financial results for the fourth quarter and full year ended December 31, 2024.
Read More
Jan De Witte joins GHO Capital as Operating Partner
Published: February 11, 2025 by: GlobeNewsWire
Sentiment: Neutral
Jan De Witte joins GHO Capital as Operating Partner Former CEO of Integra LifeSciences with significant strategic and operational experience to support GHO Capital's portfolio London, UK – 11 February 2025: Global Healthcare Opportunities, or GHO Capital Partners LLP (“GHO”), the European specialist investor in global healthcare, is pleased to announce the appointment of Jan De Witte as Operating Partner. Jan is an accomplished senior executive with extensive experience leading international growth and transformation for global technology and life sciences companies.
Read More
About Integra LifeSciences Holdings Corporation (IART)
- IPO Date 1995-08-16
- Website https://www.integralife.com
- Industry Medical - Devices
- CEO Ms. Mojdeh Poul
- Employees 4396